Found: 8 articles

Article Edition
A.S. Mochalova
Evaluation of immune response checkpoint dynamics in patients with lung cancer receiving immune therapy
№11-12 / 2022
I.B. Zhurtova, L.V. Elgarova, A.M. Gubachikova
Immune-mediated endocrine adverse events during treatment with immune checkpoint inhibitors: a clinical case of nivolumab-induced thyroiditis
№7 / 2022
S.A. Protsenko (1), A.I. Semenova (1), A.P. Oganesyan (1), E.M. Anokhina (1), A.V. Novik (1, 2)
Modern immunotherapy for kidney cancer
№7 / 2019
L.V. Filatova (1, 2)
Immunotherapy for classic Hodgkin’s lymphoma
№7 / 2019
N.V. Zhukova (1), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1), N.V. Popova (1)
EXPERIENCE OF TREATMENT with ANTI-PD-1: FROM WORLD STANDARDS TO REAL CLINICAL PRACTICE (CLINICAL OBSERVATION)
№7 / 2018
L.V. Filatova (1, 2), M.S. Motalkina (1), E.V. Kharchenko (1), I.V. Ishmatova (1), I.S. Zyuzgin (1), P.S. Shilo (1), Yu.A. Oleinik (1), Yu.A. Chudinovskikh (1), T.Yu. Semiglazova (1, 2)
TREATMENT OF RELAPSES AND RESISTANT FORMS OF HODGKIN’S LYMPHOMA
№7 / 2018
E.I. Borisova, S.L. Gutorov, M.E. Abramov
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
№17 / 2016
G.Yu. Kharkevich, K.V. Orlova, L.V. Demidov
NEW DRUGS RESTORING THE IMMUNE TUMOR CONTROL IN THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA
№17 / 2014


Бионика Медиа